KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Cash & Current Investments (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Cash & Current Investments for 16 consecutive years, with $6.6 billion as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Cash & Current Investments rose 8.03% year-over-year to $6.6 billion, compared with a TTM value of $6.6 billion through Sep 2024, up 8.03%, and an annual FY2023 reading of $8.1 billion, down 5.21% over the prior year.
  • Cash & Current Investments was $6.6 billion for Q3 2024 at Thermo Fisher Scientific, down from $8.8 billion in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $12.0 billion in Q4 2021 and bottomed at $1.9 billion in Q3 2022.
  • Average Cash & Current Investments over 5 years is $6.1 billion, with a median of $6.2 billion recorded in 2023.
  • The sharpest move saw Cash & Current Investments soared 492.3% in 2020, then plummeted 75.73% in 2022.
  • Year by year, Cash & Current Investments stood at $10.3 billion in 2020, then crashed by 56.64% to $4.5 billion in 2021, then skyrocketed by 90.4% to $8.5 billion in 2022, then dropped by 5.21% to $8.1 billion in 2023, then dropped by 17.76% to $6.6 billion in 2024.
  • Business Quant data shows Cash & Current Investments for TMO at $6.6 billion in Q3 2024, $8.8 billion in Q2 2024, and $7.3 billion in Q1 2024.